C
43.98
-0.31 (-0.70%)
| 前收盘价格 | 44.29 |
| 收盘价格 | 43.98 |
| 成交量 | 1,539,558 |
| 平均成交量 (3个月) | 914,496 |
| 市值 | 3,353,368,832 |
| 价格/销量 (P/S) | 5.22 |
| 股市价格/股市净资产 (P/B) | 4.53 |
| 52周波幅 | |
| 利润日期 | 12 Nov 2025 |
| 营业利益率 (TTM) | -81,161.54% |
| 稀释每股收益 (EPS TTM) | -1.50 |
| 季度收入增长率 (YOY) | -90.20% |
| 总债务/股东权益 (D/E MRQ) | 0.15% |
| 流动比率 (MRQ) | 30.97 |
| 营业现金流 (OCF TTM) | -81.98 M |
| 杠杆自由现金流 (LFCF TTM) | -57.18 M |
| 资产报酬率 (ROA TTM) | -12.85% |
| 股东权益报酬率 (ROE TTM) | -16.58% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | CG Oncology, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
2.0
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.0 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 2.00 |
|
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 1.17% |
| 机构持股比例 | 105.34% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Decheng Capital Llc | 30 Jun 2025 | 6,371,669 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 90.00 (Guggenheim, 104.64%) | 购买 |
| 中 | 75.00 (70.53%) | |
| 低 | 47.00 (JP Morgan, 6.87%) | 购买 |
| 平均值 | 67.29 (53.00%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 34.79 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 08 Oct 2025 | 90.00 (104.64%) | 购买 | 40.71 |
| JP Morgan | 26 Sep 2025 | 47.00 (6.87%) | 购买 | 37.54 |
| Morgan Stanley | 17 Sep 2025 | 79.00 (79.63%) | 购买 | 37.72 |
| HC Wainwright & Co. | 15 Sep 2025 | 75.00 (70.53%) | 购买 | 34.60 |
| 08 Sep 2025 | 75.00 (70.53%) | 购买 | 33.69 | |
| Cantor Fitzgerald | 08 Sep 2025 | 75.00 (70.53%) | 购买 | 33.69 |
| Jones Trading | 08 Sep 2025 | 50.00 (13.69%) | 购买 | 33.69 |
| Piper Sandler | 19 Aug 2025 | 55.00 (25.06%) | 购买 | 25.56 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合